Syringes and needles: what actually matters in practice

Dosing errors during injection usually happen at the syringe rather than the needle: misread scales, overlooked air bubbles in the barrel, and reused single-use syringes are the three mistakes that actually occur in everyday practice. This guide explains typical sources of error when drawing up, preparing, reusing, and disposing of injection syringes and provides a neutral assessment of the scientific evidence.

Reading the scales on U-100 and U-40 syringes correctly

Insulin syringes are scaled in insulin units, not milliliters. How much fluid volume corresponds to one unit is determined by the concentration for which the syringe barrel is designed: On a U-100 syringe, 100 units equal exactly one milliliter (0.01 ml per unit), while on a U-40 syringe, 40 units make up one milliliter - one unit here therefore contains 2.5 times the amount of fluid.

Confusing U-100 and U-40 syringes leads to a miscalculation by a factor of 2.5, even though the visual appearance of the barrels is barely different. This incident is documented in regulated medicine: A child drew up their usual 15 units with the wrong syringe, received 2.5 times the dose, and had to be treated in the hospital. Although the syringes are color-coded (orange versus red), reliable protection comes only from reading the scale markings carefully.

A similar conversion error threatens when switching between a syringe and an injection pen. The number on a pen marks a dose that the mechanism translates into volume, while the number on a syringe directly indicates a volume. Both scales use the term "units" but mean different values if the concentration of the cartridge does not exactly match the pen's factory calibration. When switching from a vial to a self-filled cartridge, the value must be recalculated; the injection calculator performs this conversion.

Needle gauge, needle length, and pain perception during injection

The assumption that thinner needles hurt less is based primarily on unblinded surveys where participants had prior knowledge. In a blinded comparative study without knowledge of needle size, subjects reported no difference in pain perception between thick, long and thin, short needles. Needle gauge is therefore not the primary factor in injection pain.

What demonstrably plays a role: the injection volume, the chemical composition of the fluid including additives, and the smoothness, sharpness, and prior use of the needle. A needle that has already pierced a rubber stopper loses sharpness at its tip. The fact that a thin needle burns more in one spot than a thicker one elsewhere is therefore not a contradiction but a clue pointing to everything else.

Regardless of pain, needle length determines the depth of insertion and thus where in the tissue the substance takes effect. Short needles stay more reliably in the subcutaneous fat tissue, while long needles can reach the muscle in slim individuals.

Air bubbles in the syringe: a dosing problem rather than a safety risk

Air bubbles in the subcutaneous fat tissue are medically harmless but lead to dosing inaccuracies. Each air bubble displaces fluid in the barrel, which, with very small injection volumes, can mean an error of one-fifth of the dose goes unnoticed. Bubbles that cannot be flicked away usually form during pressure equalization; injecting the same amount of air into the vial beforehand reduces their formation. The exact step-by-step procedure is described in the guide to air bubbles in the syringe.

Drawing up and storing syringes in advance

Sterile single-use syringes are, according to the relevant standard, intended exclusively for immediate use after drawing up and are not designed as storage containers. Syringes stored after filling fall outside this standard's scope and require separate approval.

Stability studies do show that prefilled syringes can be stored refrigerated for several weeks without measurable loss of active ingredient - but these data were collected with insulin and cannot be directly transferred to other peptides. Additionally, peptides can adhere to plastic surfaces; how much active ingredient is lost this way depends on the substance and is not documented for most gray-market peptides.

Filling syringes in advance extends the period during which something can go wrong, without any quality assurance. Anyone who fills syringes in advance does so without verified stability data.

Reuse of single-use syringes: risks and dead space

The sterility of a single-use syringe ends immediately upon opening the individual packaging, because the foil forms the actual sterility barrier. This applies even if the needle has not yet pierced anything. For this reason, single-use syringes are individually packaged and should only be opened immediately before injection.

Reusing a syringe carries two risks: An already used needle becomes blunt, hurts more, and irritates tissue, while residual fluid inevitably remains in the dead space of the syringe-needle combination. This dead space is small with permanently attached needles and larger with detachable needles. This was studied in the context of transmitting pathogens between people; the size itself is the same when you draw two different substances sequentially through the same syringe.

How much of substance A transfers into substance B upon reuse and what consequences that has has not been measured in the available evidence. What is certain is only that a residue remains in the dead space.

Lost injection volumes and dose calculation

Lost injection volumes due to leaks or missed doses distort the remaining-volume calculation in the vial if they are not documented. Anyone who records what actually leaves the vial does not have to estimate this; the Injection Manager tracks this and requires a free account for it.

Proper disposal of syringes and needles

Used needles and syringes must be placed immediately after injection in a puncture-proof, closable disposal container and must never go into household waste or recycling. Information on disposal sites and suitable alternative containers is provided in the article on disposing of syringes and needles.

From here on, it gets technical

The dead space of syringes was studied primarily in the context of HIV and hepatitis C transmission risk among people who inject drugs; dead-space-reduced models lower the risk but do not eliminate it. The blinded study on injection pain compared pen needles of sizes 29 gauge (12.7 mm) and 31 gauge (6 mm) and found no perceptible difference in pain perception, while in open comparisons the same people almost consistently prefer the thinner one. For the reuse of insulin syringes, there is a study from the 1980s without documented infections, which does not readily apply to today's conditions or to substances other than insulin. The governing standard for sterile single-use syringes for immediate use is ISO 7886-1.

These evidence come from regulated medicine and insulin therapy. They describe devices also used in the gray market, but they were not collected on what is in your vial.